Charles River Laboratories Operating Margin 2010-2024 | CRL

Current and historical operating margin for Charles River Laboratories (CRL) over the last 10 years. The current operating profit margin for Charles River Laboratories as of December 31, 2024 is 13.26%.
Charles River Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $4.05B $0.23B 5.60%
2024-09-30 $4.06B $0.53B 13.00%
2024-06-30 $4.08B $0.56B 13.81%
2024-03-31 $4.11B $0.58B 14.01%
2023-12-31 $4.13B $0.62B 14.97%
2023-09-30 $4.22B $0.65B 15.39%
2023-06-30 $4.18B $0.65B 15.51%
2023-03-31 $4.09B $0.67B 16.38%
2022-12-31 $3.98B $0.65B 16.37%
2022-09-30 $3.78B $0.66B 17.46%
2022-06-30 $3.69B $0.67B 18.03%
2022-03-31 $3.63B $0.62B 16.97%
2021-12-31 $3.54B $0.59B 16.69%
2021-09-30 $3.43B $0.55B 15.96%
2021-06-30 $3.27B $0.52B 16.00%
2021-03-31 $3.04B $0.46B 15.22%
2020-12-31 $2.92B $0.43B 14.81%
2020-09-30 $2.82B $0.41B 14.62%
2020-06-30 $2.75B $0.37B 13.57%
2020-03-31 $2.72B $0.38B 13.80%
2019-12-31 $2.62B $0.35B 13.42%
2019-09-30 $2.53B $0.35B 13.62%
2019-06-30 $2.45B $0.34B 13.71%
2019-03-31 $2.38B $0.33B 14.01%
2018-12-31 $2.27B $0.33B 14.61%
2018-09-30 $2.14B $0.29B 13.63%
2018-06-30 $2.02B $0.28B 13.95%
2018-03-31 $1.91B $0.29B 15.07%
2017-12-31 $1.86B $0.29B 15.56%
2017-09-30 $1.85B $0.30B 15.98%
2017-06-30 $1.81B $0.28B 15.49%
2017-03-31 $1.77B $0.26B 14.44%
2016-12-31 $1.68B $0.24B 14.09%
2016-09-30 $1.57B $0.22B 14.02%
2016-06-30 $1.49B $0.22B 14.48%
2016-03-31 $1.40B $0.21B 15.31%
2015-12-31 $1.36B $0.21B 15.11%
2015-09-30 $1.34B $0.20B 14.56%
2015-06-30 $1.32B $0.19B 14.11%
2015-03-31 $1.32B $0.18B 13.72%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.89%
2014-06-30 $1.22B $0.16B 12.86%
2014-03-31 $1.17B $0.15B 12.70%
2013-12-31 $1.17B $0.15B 13.05%
2013-09-30 $1.16B $0.16B 14.01%
2013-06-30 $1.14B $0.16B 13.91%
2013-03-31 $1.14B $0.17B 14.54%
2012-12-31 $1.13B $0.17B 14.69%
2012-09-30 $1.14B $0.17B 15.16%
2012-06-30 $1.14B $0.17B 15.09%
2012-03-31 $1.14B $0.18B 15.40%
2011-12-31 $1.14B $0.17B 15.22%
2011-09-30 $1.13B $-0.23B -20.55%
2011-06-30 $1.13B $-0.26B -23.43%
2011-03-31 $1.13B $-0.29B -25.44%
2010-12-31 $1.13B $-0.30B -26.37%
2010-09-30 $1.12B $0.10B 9.05%
2010-06-30 $1.14B $0.14B 12.17%
2010-03-31 $1.16B $0.16B 13.78%
2009-12-31 $1.17B $0.17B 14.52%
Sector Industry Market Cap Revenue
Medical Medical Services $5.761B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.368B 26.70
Elevance Health (ELV) United States $93.458B 12.06
CVS Health (CVS) United States $81.990B 12.00
Cencora (COR) United States $56.269B 20.42
Natera (NTRA) United States $20.939B 0.00
DiDi Global (DIDIY) China $20.365B 29.93
BioMerieux (BMXMF) France $15.507B 0.00
ICON (ICLR) Ireland $12.058B 10.95
EUROFINS SCIENT (ERFSF) Luxembourg $11.881B 0.00
Solventum (SOLV) United States $11.461B 10.69
CochLear (CHEOY) Australia $11.380B 0.00
Revvity (RVTY) United States $11.373B 19.20
Doximity (DOCS) United States $10.781B 56.07
Viatris (VTRS) United States $9.955B 3.15
Medpace Holdings (MEDP) United States $8.805B 23.39
Avantor (AVTR) United States $8.647B 12.56
Sonic Healthcare (SKHHY) Australia $8.152B 0.00
HealthEquity (HQY) United States $7.475B 36.77
Bausch + Lomb (BLCO) Canada $4.848B 22.13
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Alignment Healthcare (ALHC) United States $3.446B 0.00
Organon (OGN) United States $3.421B 3.45
GeneDx Holdings (WGS) United States $3.283B 389.90
Sotera Health (SHC) United States $3.210B 18.54
BrightSpring Health Services (BTSG) United States $3.069B 31.87
Surgery Partners (SGRY) United States $2.863B 32.84
Concentras Parent (CON) United States $2.815B 14.64
Progyny (PGNY) United States $1.967B 43.32
Premier (PINC) United States $1.862B 11.92
Ardent Health Partners (ARDT) United States $1.806B 0.00
GoodRx Holdings (GDRX) United States $1.788B 38.83
Agilon Health (AGL) United States $1.569B 0.00
PACS (PACS) United States $1.486B 0.00
Teladoc Health (TDOC) United States $1.285B 0.00
Pediatrix Medical (MD) United States $1.078B 9.04
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
CareDx (CDNA) United States $1.008B 17.10
Establishment Labs Holdings (ESTA) $0.873B 0.00
AMN Healthcare Services Inc (AMN) United States $0.770B 6.09
Embecta (EMBC) United States $0.730B 5.00
Nutex Health (NUTX) United States $0.579B 11.35
QDM (QDMI) Hong Kong, SAR China $0.554B 0.00
Auna S.A (AUNA) Luxembourg $0.530B 14.04
Sonida Senior Living (SNDA) United States $0.444B 0.00
InnovAge Holding (INNV) United States $0.412B 0.00
Enhabit (EHAB) United States $0.402B 37.90
LifeMD (LFMD) United States $0.384B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.349B 0.00
SBC Medicals (SBC) United States $0.347B 0.00
DocGo (DCGO) United States $0.233B 9.50
Oncology Institute (TOI) United States $0.189B 0.00
Performant Healthcare (PHLT) United States $0.184B 0.00
Beauty Health (SKIN) United States $0.125B 0.00
Sera Prognostics (SERA) United States $0.112B 0.00
OncoCyte (OCX) United States $0.089B 0.00
Ascend Wellness Holdings (AAWH) United States $0.084B 0.00
So-Young (SY) China $0.084B 0.00
Biodesix (BDSX) United States $0.078B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
IceCure Medical (ICCM) Israel $0.070B 0.00
NeueHealth (NEUE) United States $0.057B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.021B 0.00
ModivCare (MODV) United States $0.018B 6.32
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00